UltraTech Cement shares jump 1% as brokerages increase target price after Q3 results. Should you invest?
UltraTech Cement shares rose 1% following strong Q3 results, with a 17% YoY profit decline but revenue exceeding estimates. Brokerages remain positive, with target prices ranging from Rs 12,100 to Rs ...
India Today43m
Explained: Why Dr Reddy's share price cracked 6% in early trade
Dr Reddy’s shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay Stock Exchange (BSE).
Dr Reddy's Laboratories share price declines 6% post Q3 results: Should you Buy, Sell or Hold
Dr Reddy's Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday ...
Dr. Reddy’s to focus on complex products as growth drivers to offset Revlimid revenue loss
Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1s (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...